Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 200kHz) concomitant with weeklypaclitaxel for the treatment of platinum-resistant ovarian cancer (PROC).
PARTNERZY
PARTNERZY
Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 200kHz) concomitant with weeklypaclitaxel for the treatment of platinum-resistant ovarian cancer (PROC).